Syndax Pharmaceuticals (Germany) Top Insiders
1T3 Stock | EUR 12.80 0.10 0.78% |
Syndax Pharmaceuticals employs about 59 people. The company is managed by 10 executives with a total tenure of roughly 138 years, averaging almost 13.0 years of service per executive, having 5.9 employees per reported executive. Examination of Syndax Pharmaceuticals' management performance can provide insight into the company performance.
Michael MBA CEO CEO Director |
Syndax |
Syndax Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.0292) % which means that it has lost $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0519) %, meaning that it generated substantial loss on money invested by shareholders. Syndax Pharmaceuticals' management efficiency ratios could be used to measure how well Syndax Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Syndax Pharmaceuticals Workforce Comparison
Syndax Pharmaceuticals is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 22,737. Syndax Pharmaceuticals adds roughly 59.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11. Syndax Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Syndax Pharmaceuticals Price Series Summation is a cross summation of Syndax Pharmaceuticals price series and its benchmark/peer.
Syndax Pharmaceuticals Notable Stakeholders
A Syndax Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Syndax Pharmaceuticals often face trade-offs trying to please all of them. Syndax Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Syndax Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronald Evans | Advisor CoFounder | Profile | |
Peter BSc | CoFounder Officer | Profile | |
Richard Heyman | CoFounder | Profile | |
Michael Downes | CoFounder | Profile | |
Michael MBA | CEO Director | Profile | |
Sharon Klahre | VP Communications | Profile | |
Alexander Nolte | VP Officer | Profile | |
Briggs MD | Head Pres | Profile | |
Anjali Ganguli | Chief Officer | Profile | |
Keith CPA | Chief Officer | Profile |
About Syndax Pharmaceuticals Management Performance
The success or failure of an entity such as Syndax Pharmaceuticals often depends on how effective the management is. Syndax Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Syndax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Syndax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company was founded in 2005 and is headquartered in Waltham, Massachusetts. Syndax Pharmaceuticals operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38 people.
Syndax Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Syndax Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Syndax Pharmaceuticals within its industry.Syndax Pharmaceuticals Manpower Efficiency
Return on Syndax Pharmaceuticals Manpower
Revenue Per Employee | 2.4M | |
Revenue Per Executive | 14M | |
Net Income Per Employee | 422.5K | |
Net Income Per Executive | 2.5M |
Complementary Tools for Syndax Stock analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |